Spironolactone use and the risk of breast and gynecologic cancers

Biggar, Bob, Anderson, Elisabeth, Wohlfahrt, Jan, & Melbye, Mads (2013) Spironolactone use and the risk of breast and gynecologic cancers. Cancer Epidemiology, 37(6), pp. 870-875.

View at publisher

Impact and interest:

9 citations in Scopus
Search Google Scholar™
8 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 76961
Item Type: Journal Article
Refereed: Yes
Keywords: estrogen, furosemide, prescription drug, spironolactone, adult, aged, article, breast cancer, cancer diagnosis, cancer incidence, cancer risk, drug use, female, gynecologic cancer, human, major clinical study, priority journal, risk assessment, uterine c
DOI: 10.1016/j.canep.2013.10.004
ISSN: 1877-7821
Divisions: Past > QUT Faculties & Divisions > Faculty of Built Environment and Engineering
Current > Institutes > Institute of Health and Biomedical Innovation
Deposited On: 07 Oct 2014 07:00
Last Modified: 07 Oct 2014 07:05

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page